药物诱导性肝衰竭患者的韦尼克脑病变:一个病例报告
Jiao-Jiao Cao1, Jing Li1, Yan Cheng1
1Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Frontiers in nutrition
|January 23, 2025
概括
维尼克脑病,通常与酒和维生素B1缺乏有关,可以在没有酒精的情况下发生. 早期诊断和维生素B1治疗对于扭转症状至关重要,即使在非酒精病例中也是如此.
科学领域:
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
- 营养缺乏症 营养缺乏症
背景情况:
- 沃尼克脑病是一种严重的代谢疾病,主要与维生素B1 (胺) 缺乏有关.
- 虽然在慢性酒中很常见,但非酒精性韦尼克脑病也会给诊断带来挑战.
- 早期识别和干预对于患者的治疗结果至关重要.
研究的目的:
- 突出非酒精性韦尼克脑病变的诊断困难.
- 强调及时补充维生素B1的重要性.
- 为了说明及时治疗的症状逆转的潜力.
主要方法:
- 一个62岁的男性患者的病例报告,他患有药物诱导的肝衰竭.
- 临床表现包括下肢虚弱和意识改变.
- 通过MRI和维生素B1水平测试证实了诊断.
主要成果:
- 磁共振成像揭示了T2加权和扩散加权图像上的经典对称超强信号.
- 这些特征性的MRI发现在静脉注射维生素B1后是可逆的.
- 患者的神经症状在补充药物后有所改善.
结论:
- 临床怀疑的高指数对于诊断维尼克脑病变至关重要,特别是在非酒精环境中.
- 治疗干预需要立即补充维生素B1,这是必要的.
- 在可逆阶段及时治疗可以预防不可逆的神经损伤.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


